Long-term use of valproic acid and the prevalence of cancers in bipolar

Long-term use of valproic acid and the prevalence of cancers in bipolar disorder patients in a Taiwanese population: An association analysis using the National Health Insurance Research Database (NHIRD)

Journal of Affective Disorders Mar 24, 2018

Lin CC, et al. - The effects of exposure to the anticonvulsant agent valproic acid (VPA), a histone deacetylase inhibitor, on the risk of developing cancers were evaluated in a retrospective cohort study. In cancer prevention, VPA was found to have no role. Researchers identified VPA association with an increased subgroup risk of genitourinary cancer in the treatment duration Go to Original

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.

4 reasons why Doctors love M3 India

Exclusive Write-ups & Webinars by KOLs
Daily Quiz by specialty
Paid Market Research Surveys
Case discussions, News & Journals' summaries

Sign-up / Log In